hrs4r
Quiero donar

JAVIER ABEL MENÉNDEZ MENÉNDEZ

Firma
JAVIER ABEL MENÉNDEZ-MENÉNDEZ
Posición
Cap de Grup - R4
Jefe de Grupo - R4

Projectes

Codi oficial: PID2019-104055GB-I00 Data inicio:01/06/2020 Data fi: 31/05/2023 Investigador/a principal: JAVIER ABEL MENÉNDEZ MENÉNDEZ Organisme finançador: MINISTERIO DE ECONOMIA Y COMPETITIVIDAD MINECO / Ajuda: 242,000 €
Codi oficial: CP20/00003 Data inicio:01/01/2021 Data fi: 31/12/2025 Investigador/a principal: ELISABET CUYÀS NAVARRO Organisme finançador: INSTITUTO DE SALUD CARLOS III Ajuda: 202,500 €

Publicacions

Espinoza I, Yang L, Steen TV, Vellon L, Cuyàs E, Verdura S, Lau L, Menendez JA, Lupu R

Binding of the angiogenic/senescence inducer CCN1/CYR61 to integrin a 6 ß 1 drives endocrine resistance in breast cancer cells.

Aging-Us, 2022, 14, 1200-1213 dx.doi.org/10.18632/aging.203882
0

Fatty acid synthase: a druggable driver of breast cancer brain metastasis.

EXPERT OPINION ON THERAPEUTIC TARGETS, 2022, 26, 1-18 dx.doi.org/10.1080/14728222.2022.2077189
0

Nuclear moonlighting of the secreted growth factor heregulin drives endocrine-resistant breast cancer independently of HER2/HER3 signaling

AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12, 2173-2188
0

Metformin and breast cancer: an opportunity for pharmacogenetics.

Aging-Us, 2022, 14, 5612-5613 dx.doi.org/10.18632/aging.204180
0

Laparoscopic Sleeve Gastrectomy in Patients with Severe Obesity Restores Adaptive Responses Leading to Nonalcoholic Steatohepatitis.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 dx.doi.org/10.3390/ijms23147830

Tramonti A, Cuyàs E, Encinar JA, Pietzke M, Paone A, Verdura S, Arbusà A, Martin-Castillo B, Giardina G, Joven J, Vazquez A, Contestabile R, Cutruzzolà F, Menendez JA

Metformin Is a Pyridoxal-5'-phosphate (PLP)-Competitive Inhibitor of SHMT2.

Cancers, 2021, 13 dx.doi.org/10.3390/cancers13164009

Bosch-Barrera J, Verdura S, Ruffinelli JC, Carcereny E, Sais E, Cuyàs E, Palmero R, Lopez-Bonet E, Hernández-Martínez A, Oliveras G, Buxó M, Izquierdo A, Morán T, Nadal E, Menendez JA

Silibinin Suppresses Tumor Cell-Intrinsic Resistance to Nintedanib and Enhances Its Clinical Activity in Lung Cancer.

Cancers, 2021, 13 dx.doi.org/10.3390/cancers13164168

Verdura S, Cuyàs E, Ruiz-Torres V, Micol V, Joven J, Bosch-Barrera J, Menendez JA

Lung Cancer Management with Silibinin: A Historical and Translational Perspective.

Pharmaceuticals, 2021, 14 dx.doi.org/10.3390/ph14060559

Menendez JA, Papadimitropoulou A, Vander Steen T, Cuyàs E, Oza-Gajera BP, Verdura S, Espinoza I, Vellon L, Mehmi I, Lupu R

Fatty Acid Synthase Confers Tamoxifen Resistance to ER+/HER2+ Breast Cancer.

Cancers, 2021, 13 dx.doi.org/10.3390/cancers13051132

Castañé H, Baiges-Gaya G, Hernández-Aguilera A, Rodríguez-Tomàs E, Fernández-Arroyo S, Herrero P, Delpino-Rius A, Canela N, Menendez JA, Camps J, Joven J

Coupling Machine Learning and Lipidomics as a Tool to Investigate Metabolic Dysfunction-Associated Fatty Liver Disease. A General Overview.

Biomolecules, 2021, 11 dx.doi.org/10.3390/biom11030473

Formulari de contacte

Conoce el IDIBGI!

menu